Subscribe To
Standard BioTools Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Business Outlook
Fourth quarter 2022 GAAP revenues of $27.0 million; Core product and service revenues of $26.8 million, representing 8.3% sequential growth; Full year GAAP revenues of $97.9 million and core product and service revenues of $94.5 million Improved operating discipline and restructuring initiatives contributed to a 16% sequential decrease in operating expenses in the fourth quarter; […] The post Standard BioTools Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Business...
Read More
Posted: Feb 14 2023, 21:05
Author Name: forextv
Views: 082282